Paper36216147
CD55 in cancer: Complementing functions in a non-canonical manner.
Bharti R and 4 others. Cancer Lett, 2022. Cited by 43 papers, by iCite.
Cite this record
ConductScience Library. CD55 in cancer: Complementing functions in a non-canonical manner. Papers, record 36216147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36216147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| CD55 Antigens | Major topic |
| Neoplasm Recurrence, Local | Major topic |
| Humans | |
| Signal Transduction | |
| Apoptosis |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 EY032458 | NEI NIH HHS | United States | R01EY032458 | PubMed and NIH | NIH RePORTER |
| R41 CA275639 | NCI NIH HHS | United States | R41CA275639 | PubMed | NIH RePORTER |
References93
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20879979 | Inhibition of membrane complement inhibitor expression (CD46, CD55, CD59) by siRNA sensitizes tumor cells to complement attack in vitro. | Curr Cancer Drug Targets | 2010 | https://conductscience.org/library/papers/20879979 | PubMed |
| 2 | 34655293 | Human embryonic stem cell-derived neural crest model unveils CD55 as a cancer stem cell regulator for therapeutic targeting in MYCN-amplified neuroblastoma. | Neuro Oncol | 2022 | https://conductscience.org/library/papers/34655293 | PubMed |
| 3 | 29888202 | The Interaction of CD97/ADGRE5 With β-Catenin in Adherens Junctions Is Lost During Colorectal Carcinogenesis. | Front Oncol | 2018 | https://conductscience.org/library/papers/29888202 | PubMed |
| 4 | 33888137 | Pretreatment with LCK inhibitors chemosensitizes cisplatin-resistant endometrioid ovarian tumors. | J Ovarian Res | 2021 | https://conductscience.org/library/papers/33888137 | PubMed |
| 5 | 28516949 | Paroxysmal nocturnal haemoglobinuria. | Nat Rev Dis Primers | 2017 | https://conductscience.org/library/papers/28516949 | PubMed |
| 6 | 25797618 | Complement inhibitor CD55 governs the integrity of membrane rafts in pancreatic beta cells, but plays no role in insulin secretion. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25797618 | PubMed |
| 7 | 25624904 | Expression and prognostic value of CD97 and its ligand CD55 in pancreatic cancer. | Oncol Lett | 2015 | https://conductscience.org/library/papers/25624904 | PubMed |
| 8 | 30590044 | Mutations in an Innate Immunity Pathway Are Associated with Poor Overall Survival Outcomes and Hypoxic Signaling in Cancer. | Cell Rep | 2018 | https://conductscience.org/library/papers/30590044 | PubMed |
| 9 | 28345461 | Expression and prognostic value of soluble CD97 and its ligand CD55 in intrahepatic cholangiocarcinoma. | Tumour Biol | 2017 | https://conductscience.org/library/papers/28345461 | PubMed |
| 10 | 8667608 | Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. | Lab Invest | 1996 | https://conductscience.org/library/papers/8667608 | PubMed |
| 11 | 26807645 | Hypoxia and metabolic adaptation of cancer cells. | Oncogenesis | 2016 | https://conductscience.org/library/papers/26807645 | PubMed |
| 12 | 31487060 | CD55 Regulates Bone Mass in Mice by Modulating RANKL-Mediated Rac Signaling and Osteoclast Function. | J Bone Miner Res | 2020 | https://conductscience.org/library/papers/31487060 | PubMed |
| 13 | 2450893 | Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2450893 | PubMed |
| 14 | 20339853 | The impact of expressions of CD97 and its ligand CD55 at the invasion front on prognosis of rectal adenocarcinoma. | Int J Colorectal Dis | 2010 | https://conductscience.org/library/papers/20339853 | PubMed |
| 15 | 19662541 | Expression of complement regulatory proteins: CD46, CD55, and CD59 and response to rituximab in patients with CD20+ non-Hodgkin's lymphoma. | Med Oncol | 2010 | https://conductscience.org/library/papers/19662541 | PubMed |
| 16 | 11139317 | CD55 is over-expressed in the tumour environment. | Br J Cancer | 2001 | https://conductscience.org/library/papers/11139317 | PubMed |
| 17 | 29895866 | Development of a radionuclide-labeled monoclonal anti-CD55 antibody with theranostic potential in pleural metastatic lung cancer. | Sci Rep | 2018 | https://conductscience.org/library/papers/29895866 | PubMed |
| 18 | 28657829 | CD55 Deficiency, Early-Onset Protein-Losing Enteropathy, and Thrombosis. | N Engl J Med | 2017 | https://conductscience.org/library/papers/28657829 | PubMed |
| 19 | 28920587 | Complement in cancer: untangling an intricate relationship. | Nat Rev Immunol | 2018 | https://conductscience.org/library/papers/28920587 | PubMed |
| 20 | 16683005 | Mechanisms of disease: understanding resistance to HER2-targeted therapy in human breast cancer. | Nat Clin Pract Oncol | 2006 | https://conductscience.org/library/papers/16683005 | PubMed |
Cited by34
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 43 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42948382 | HnRNPF extensively regulates expression and alternative splicing of genes associated with proliferation and migration in gastric cancer cells. | Biomed Rep | 2026 | https://conductscience.org/library/papers/42948382 | PubMed |
| 42693249 | CD55 organizes lipid raft-LCK signaling to potentiate NK-cell antitumor immunity. | Cell Res | 2026 | https://conductscience.org/library/papers/42693249 | PubMed |
| 42432656 | Stress-induced CD55 supports homologous recombination capacity and drives oxaliplatin resistance in colorectal cancer. | Cell Commun Signal | 2026 | https://conductscience.org/library/papers/42432656 | PubMed |
| 42165710 | Asynchronous Evolution of Epithelium and Stroma Differentiates Precursor Lesions from Pancreatic Cancer. | Cancer Discov | 2026 | https://conductscience.org/library/papers/42165710 | PubMed |
| 42091754 | Protein expression profiling of lenvatinib-resistant liver cancer cells and identify B4GALT4 as a critical drug resistance molecule. | Discov Oncol | 2026 | https://conductscience.org/library/papers/42091754 | PubMed |
| 42089302 | Immune regulation by CD55 in chronic beryllium disease. | Am J Respir Cell Mol Biol | 2026 | https://conductscience.org/library/papers/42089302 | PubMed |
| 41946696 | GDPD5-CD55-EGFR competitive binding axis regulates radioresistance and lipid accumulation in rectal cancer. | Cell Death Dis | 2026 | https://conductscience.org/library/papers/41946696 | PubMed |
| 41819546 | Complement system in cancer: friend or foe of immunotherapy. | J Immunother Cancer | 2026 | https://conductscience.org/library/papers/41819546 | PubMed |
| 41563994 | Identification of hypoxia- and mitophagy-related diagnostic biomarkers for ulcerative colitis based on bioinformatic analysis and machine learning. | PLoS One | 2026 | https://conductscience.org/library/papers/41563994 | PubMed |
| 41504495 | ROS Activated NETosis of Bone Marrow CD55+ Intermediate Mature Neutrophils Through HIF1α-PADI4 Pathway to Initiate Bone Aging. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/41504495 | PubMed |
| 41325834 | Identification of marginal zone B cells in head and neck cancer with immunomodulatory characteristics. | J Adv Res | 2026 | https://conductscience.org/library/papers/41325834 | PubMed |
| 41031890 | The complement system in intestinal inflammation and cancer. | J Clin Invest | 2025 | https://conductscience.org/library/papers/41031890 | PubMed |
| 41006678 | Single-cell RNA-sequencing of BCG naïve and recurrent non-muscle invasive bladder cancer reveals a CD6/ALCAM-mediated immune-suppressive pathway. | NPJ Precis Oncol | 2025 | https://conductscience.org/library/papers/41006678 | PubMed |
| 40862775 | The Function of Transforming Growth Factor 2 in Facilitating Inflammasome Activation to Enhance the Development of Myopia via Complement System. | Cells | 2025 | https://conductscience.org/library/papers/40862775 | PubMed |
| 40796955 | Activated MAFB in ovarian cancer promotes cytoskeletal remodeling and immune microenvironment suppression by interfering with m6A modifications through WTAP competition. | Oncogene | 2025 | https://conductscience.org/library/papers/40796955 | PubMed |
| 40725231 | Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40725231 | PubMed |
| 40419851 | The decay-accelerating factor (CD55) in acute leukemia patients and its query implication in cancer pathogenesis. | J Egypt Natl Canc Inst | 2025 | https://conductscience.org/library/papers/40419851 | PubMed |
| 40419651 | Whole-blood transcriptomic analysis reveals preoperative complement inhibitor deficiencies linked to postoperative delirium. | Mol Psychiatry | 2025 | https://conductscience.org/library/papers/40419651 | PubMed |
| 40242505 | Nanotherapeutic strategies exploiting biological traits of cancer stem cells. | Bioact Mater | 2025 | https://conductscience.org/library/papers/40242505 | PubMed |
| 40106166 | Bioinformatic analysis of serpina1 expression in papillary thyroid carcinoma and its potential association with Hashimoto's thyroiditis. | Discov Oncol | 2025 | https://conductscience.org/library/papers/40106166 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD55 | 1604 | PubTator's text mining | https://conductscience.org/library/genes/1604 | NCBI Gene |
| LCK | 3932 | PubTator's text mining | https://conductscience.org/library/genes/3932 | NCBI Gene |
| MAPK8 | 5599 | PubTator's text mining | https://conductscience.org/library/genes/5599 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36216147
GET https://conductscience.org/api/papers/v1/36216147/references?page=2